documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
11,406 rows where agency_id = "FDA" and posted_year = 2014 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_month, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 5
- Supporting & Related Material 6,510
- Other 3,752
- Notice 932
- Proposed Rule 116
- Rule 96
posted_year 1
- 2014 · 11,406 ✖
agency_id 1
- FDA · 11,406 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-S-0024-0493 | FDA | FDA-2013-S-0024 | Highland Laboratories (Good Niacin) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:50:53Z | 0 | 0 | 09000064819919ad | ||
| FDA-2013-S-0024-0485 | FDA | FDA-2013-S-0024 | Highland Laboratories (Liquid Quercetin Nettle) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:16:03Z | 0 | 0 | 0900006481991981 | ||
| FDA-2013-S-0024-0501 | FDA | FDA-2013-S-0024 | Highland Laboratories (Nice Bones) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T16:16:43Z | 0 | 0 | 09000064819919ae | ||
| FDA-2013-S-0024-0492 | FDA | FDA-2013-S-0024 | Highland Laboratories (B12 Liquid) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:47:01Z | 0 | 0 | 09000064819919a5 | ||
| FDA-2013-S-0024-0495 | FDA | FDA-2013-S-0024 | Highland Laboratories (One Good Multi) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:56:31Z | 0 | 0 | 09000064819919a7 | ||
| FDA-2014-V-2320-0001 | FDA | FDA-2014-V-2320 | Acknowledgement Letter From FDA DDM to Extensive Music Sweden AB | Other | Acknowledgement Letter/Receipt | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T12:37:14Z | 0 | 0 | 090000648199b074 | ||
| FDA-2014-D-2065-0002 | FDA | FDA-2014-D-2065 | Radiation Biodosimetry Devices Draft Guidance for Industry and Food and Drug Administration Staff | Other | Guidance | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2024-11-12T05:31:58Z | 1 | 0 | 090000648199accc | ||
| FDA-2013-S-0024-0503 | FDA | FDA-2013-S-0024 | Highland Laboratories (Raspberry Ketones) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T16:22:19Z | 0 | 0 | 09000064819919b0 | ||
| FDA-2013-S-0024-0479 | FDA | FDA-2013-S-0024 | Highland Laboratories - Cold Facts + Vitamin D - Supports healthy immune function | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2017-06-12T20:55:53Z | 0 | 0 | 0900006481990c8e | |||
| FDA-2013-S-0024-0483 | FDA | FDA-2013-S-0024 | Highland Laboratories (Quercetin Nettle) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:11:42Z | 0 | 0 | 090000648199197f | ||
| FDA-2013-S-0024-0489 | FDA | FDA-2013-S-0024 | Highland Laboratories (Immun-D) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:33:13Z | 0 | 0 | 090000648199198f | ||
| FDA-2013-S-0024-0488 | FDA | FDA-2013-S-0024 | Highland Laboratories (Sweet Sleep) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:30:22Z | 0 | 0 | 0900006481991984 | ||
| FDA-2013-S-0024-0482 | FDA | FDA-2013-S-0024 | Highland Laboratories (Eye Factors) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:09:46Z | 0 | 0 | 090000648199197e | ||
| FDA-2013-S-0024-0499 | FDA | FDA-2013-S-0024 | Highland Laboratories (Good Fizzy Mins) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T16:07:15Z | 0 | 0 | 09000064819919ab | ||
| FDA-2013-S-0024-0490 | FDA | FDA-2013-S-0024 | Highland Laboratories (Good Vitamin D) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:37:24Z | 0 | 0 | 09000064819919a3 | ||
| FDA-2013-S-0024-0487 | FDA | FDA-2013-S-0024 | Highland Laboratories (Everyday Liquid Sunshine) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:22:50Z | 0 | 0 | 0900006481991983 | ||
| FDA-2013-S-0024-0500 | FDA | FDA-2013-S-0024 | Highland Laboratories (Good Osteo) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T16:10:20Z | 0 | 0 | 09000064819919ac | ||
| FDA-2013-S-0024-0481 | FDA | FDA-2013-S-0024 | Highland Laboratories (Estro-Good) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:05:45Z | 0 | 0 | 090000648199197d | ||
| FDA-2013-S-0024-0498 | FDA | FDA-2013-S-0024 | Highland Laboratories (Womens 50+ Multi) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T16:05:12Z | 0 | 0 | 09000064819919aa | ||
| FDA-2014-N-1484-0001 | FDA | FDA-2014-N-1484 | Revisions to Exceptions Applicable to Certain Human Cells Tissues and Cellular and Tissue-Based Products | Proposed Rule | Amendment | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2015-04-01T03:59:59Z | 2015-04-01T02:01:23Z | 2014-30528 | 0 | 0 | 090000648199bdf0 |
| FDA-2013-S-0024-0480 | FDA | FDA-2013-S-0024 | Highland Laboratories (D-Tox) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:02:22Z | 0 | 0 | 090000648199197c | ||
| FDA-2014-D-2254-0001 | FDA | FDA-2014-D-2254 | The Drug Supply Chain Security Act Implementation Product Tracing Requirements Compliance Policy Guidance for Industry Availability | Notice | Notice of Availability | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2024-11-12T05:33:45Z | 2014-30608 | 1 | 0 | 090000648199bfdc | |
| FDA-2013-S-0024-0497 | FDA | FDA-2013-S-0024 | Highland Laboratories (Mens 50+ Multi) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T16:02:12Z | 0 | 0 | 09000064819919a9 | ||
| FDA-2013-S-0024-0484 | FDA | FDA-2013-S-0024 | Highland Laboratories (PARA Response) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:13:47Z | 0 | 0 | 0900006481991980 | ||
| FDA-2013-S-0024-0486 | FDA | FDA-2013-S-0024 | Highland Laboratories (Water Away) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:20:58Z | 0 | 0 | 0900006481991982 | ||
| FDA-2013-S-0024-0491 | FDA | FDA-2013-S-0024 | Highland Laboratories (Triple B12 Dots) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:39:03Z | 0 | 0 | 09000064819919a4 | ||
| FDA-2013-S-0024-0494 | FDA | FDA-2013-S-0024 | Highland Laboratories (Good C) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:53:27Z | 0 | 0 | 09000064819919a6 | ||
| FDA-2013-S-0024-0496 | FDA | FDA-2013-S-0024 | Highland Laboratories (Simply 4 Energy) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T15:59:31Z | 0 | 0 | 09000064819919a8 | ||
| FDA-2014-V-2320-0002 | FDA | FDA-2014-V-2320 | Variance Application Request from Extensive Music Sweden AB | Other | Application for Variance (VAR) | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T12:37:28Z | 0 | 0 | 090000648199ab9c | ||
| FDA-2013-S-0024-0502 | FDA | FDA-2013-S-0024 | Highland Laboratories (Strontium Bone Power) - Letter | Other | 30 Day Structured Function Claim | 2014-12-31T05:00:00Z | 2014 | 12 | 2014-12-31T05:00:00Z | 2014-12-31T16:18:59Z | 0 | 0 | 09000064819919af | ||
| FDA-2014-N-1936-0002 | FDA | FDA-2014-N-1936 | Electronic Cigarettes and the Public Health Public Workshop | Notice | Meeting | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2015-03-04T12:21:12Z | 2014-30450 | 0 | 0 | 0900006481999bbf | |
| FDA-2014-V-2309-0001 | FDA | FDA-2014-V-2309 | Variance Application Request from Carestream Health Inc | Other | Application for Variance (VAR) | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T17:35:53Z | 0 | 0 | 0900006481997959 | ||
| FDA-2014-V-1705-0003 | FDA | FDA-2014-V-1705 | TECHNIC SOUNDZ ENTERTAINMENT Variance Approval | Other | Approval for Variance (VRA) | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T18:36:15Z | 0 | 0 | 090000648199a915 | ||
| FDA-2014-V-2309-0002 | FDA | FDA-2014-V-2309 | Acknowledgement Letter from FDA DDM to Caresteam Health Inc | Other | Acknowledgement Letter/Receipt | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T17:36:02Z | 0 | 0 | 090000648199a273 | ||
| FDA-2007-D-0369-0310 | FDA | FDA-2007-D-0369 | Draft and Revised Draft Guidances for Industry Describing Product Specific Bioequivalence Recommendations Availability | Notice | Notice of Availability | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2015-03-03T04:59:59Z | 2024-11-12T05:29:27Z | 2014-30514 | 1 | 0 | 0900006481999bc7 |
| FDA-2014-V-2316-0001 | FDA | FDA-2014-V-2316 | Variance Application Request from Richard Astley | Other | Application for Variance (VAR) | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T20:39:16Z | 0 | 0 | 090000648199a98d | ||
| FDA-2014-V-2308-0002 | FDA | FDA-2014-V-2308 | Acknowledgement Letter from FDA DDM to Carestream Health Inc | Other | Acknowledgement Letter/Receipt | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T17:05:52Z | 0 | 0 | 09000064819990fd | ||
| FDA-2006-N-0515-0091 | FDA | Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling FDA-2006-N-0515 | Reference 4 Evaluation of How Best to Communicate with Healthcare Providers about the Risks and Benefits of Prescription Drug Use for Pregnant and Nursing Women A Mental Models Research Report Final Report re Ref2 Final Regulatory Impact Analysis for Docket No. FDA-2006-N-0515 (formerly Docket No. 2006N-0467) | Supporting & Related Material | Background Material | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T18:22:18Z | 0 | 0 | 090000648199a463 | |||
| FDA-2014-V-2319-0002 | FDA | FDA-2014-V-2319 | Acknowledgement Letter from FDA DDM to Wibs | Other | Acknowledgement Letter/Receipt | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T20:44:10Z | 0 | 0 | 090000648199ab99 | ||
| FDA-2014-V-2308-0001 | FDA | FDA-2014-V-2308 | Variance Application Request from Carestream Health Inc | Other | Application for Variance (VAR) | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T17:05:31Z | 0 | 0 | 0900006481997957 | ||
| FDA-2014-N-0797-0002 | FDA | FDA-2014-N-0797 | Agency Information Collection Activities; Submission for Office of Management and Budget Review Comment Request Guidance Medical Device ISO 13485 2003 Voluntary Audit Report Submission Pilot Program | Notice | 30 Day Proposed Information Collection | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2015-01-30T04:59:59Z | 2014-12-30T17:02:11Z | 2014-30513 | 0 | 0 | 0900006481999c8a |
| FDA-2014-N-1027-0003 | FDA | FDA-2014-N-1027 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approval Infant Formula Recall Regulations | Notice | Notice of Approval | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T17:09:20Z | 2014-30461 | 0 | 0 | 0900006481999d89 | |
| FDA-2014-D-2065-0001 | FDA | FDA-2014-D-2065 | Radiation Biodosimetry Devices Draft Guidance for Industry and Food and Drug Administration Staff Availability | Notice | Notice of Availability | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2015-03-31T03:59:59Z | 2024-11-12T05:30:49Z | 2014-30453 | 1 | 0 | 09000064819999f5 |
| FDA-2014-V-2319-0001 | FDA | FDA-2014-V-2319 | Variance Application Request from Wibs | Other | Application for Variance (VAR) | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T20:44:01Z | 0 | 0 | 090000648199ae5c | ||
| FDA-2014-E-2321-0002 | FDA | FDA-2014-E-2321 | Patent Extension Application from Hyperion on Behalf of Brusilow Enterprises LLC | Other | Application | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2015-01-07T22:00:23Z | 0 | 0 | 090000648199acc9 | ||
| FDA-2011-N-0920-1938 | FDA | FDA-2011-N-0920 | Supplement from the California Dried Plum Board | Other | Supplement (SUP) | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T15:48:53Z | 0 | 0 | 090000648197c7db | ||
| FDA-2014-V-2315-0001 | FDA | FDA-2014-V-2315 | Variance Application Request from 727 BUILDING | Other | Application for Variance (VAR) | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T20:36:34Z | 0 | 0 | 090000648199a446 | ||
| FDA-2014-V-2315-0002 | FDA | FDA-2014-V-2315 | Acknowledgement Letter from FDA DDM to 727 BUILDING | Other | Acknowledgement Letter/Receipt | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T20:36:41Z | 0 | 0 | 090000648199a992 | ||
| FDA-2014-P-1065-0007 | FDA | FDA-2014-P-1065 | Citizen Petition Approval Response Letter from FDA CDER to Zydus Pharmaceuticals Inc | Other | Approval | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T17:46:49Z | 0 | 0 | 0900006481999f0d | ||
| FDA-2014-P-0646-0002 | FDA | FDA-2014-P-0646 | Letter from Kamat Pharmatech to FDA/DDM | Other | Letter(s) | 2014-12-30T05:00:00Z | 2014 | 12 | 2015-01-08T15:29:29Z | 0 | 0 | 090000648199a275 | |||
| FDA-2011-N-0921-1481 | FDA | FDA-2011-N-0921 | Supplement from the California Dried Plum Board | Other | Supplement (SUP) | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T15:19:24Z | 0 | 0 | 090000648197cb43 | ||
| FDA-2014-V-2316-0002 | FDA | FDA-2014-V-2316 | Acknowledgement Letter from FDA DDM to Richard Astley | Other | Acknowledgement Letter/Receipt | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T20:39:33Z | 0 | 0 | 090000648199a7d3 | ||
| FDA-1989-V-0020-0004 | FDA | Laser Light Show Re: Omnichrome Laser FDA-1989-V-0020 | Letter from FDA CDRH to Faith's Sound & Light, Inc. | Other | Approval for Variance (VRA) | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2024-03-01T13:34:37Z | 0 | 0 | 090000648199a98f | ||
| FDA-2014-N-0998-0002 | FDA | FDA-2014-N-0998 | Agency Information Collection Activities Submission for Office of Management and Budget Review Comment Request Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring | Notice | 30 Day Proposed Information Collection | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2015-01-30T04:59:59Z | 2015-03-08T19:42:01Z | 2014-30452 | 0 | 0 | 0900006481999bc3 |
| FDA-2013-P-1552-0001 | FDA | FDA-2013-P-1552 | Citizen Petition from Hearing Industries Association (HIA) | Other | Citizen Petition | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2016-03-14T13:42:23Z | 0 | 0 | 09000064814c28cb | ||
| FDA-2014-E-2321-0001 | FDA | FDA-2014-E-2321 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T22:10:34Z | 0 | 0 | 090000648199ab9e | ||
| FDA-2014-V-2318-0001 | FDA | FDA-2014-V-2318 | Variance Application Request from B&L Motorsports | Other | Application for Variance (VAR) | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T20:41:35Z | 0 | 0 | 090000648199ad0b | ||
| FDA-2014-P-0646-0003 | FDA | FDA-2014-P-0646 | Letter from Kamat Pharmatech to FDA/DDM | Other | Letter(s) | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2016-09-15T19:10:05Z | 0 | 0 | 090000648199a464 | ||
| FDA-2014-N-0001-0104 | FDA | FDA-2014-N-0001 | Science Board to the Food and Drug Administration Notice of Meeting | Notice | Public Meetings | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T15:34:56Z | 2014-30516 | 0 | 0 | 0900006481999ad1 | |
| FDA-2013-P-1552-0002 | FDA | FDA-2013-P-1552 | Letter from FDA CDRH to Hearing Industries Association | Other | Letter(s) | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2016-03-14T13:43:29Z | 0 | 0 | 09000064814ac78b | ||
| FDA-2011-N-0672-0003 | FDA | FDA-2011-N-0672 | Agency Information Collection Activities Proposed Collection Comment Request Prominent and Conspicuous Mark of Manufacturers on Single-Use Devices | Notice | 60 Day Proposed Information Collection | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2015-03-03T04:59:59Z | 2015-04-08T13:06:22Z | 2014-30511 | 0 | 0 | 0900006481999b05 |
| FDA-2014-V-2318-0002 | FDA | FDA-2014-V-2318 | Acknowledgement Letter from FDA DDM to B&L Motorsports | Other | Acknowledgement Letter/Receipt | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T20:41:48Z | 0 | 0 | 090000648199ab97 | ||
| FDA-2014-N-0001-0105 | FDA | FDA-2014-N-0001 | Guidance: Advisory Committees; Filing of Closed Meeting Reports | Notice | Report Submissions | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T05:00:00Z | 2014-12-30T16:05:56Z | 2014-30460 | 0 | 0 | 0900006481999b53 | |
| FDA-2011-E-0117-0008 | FDA | FDA-2011-E-0117 | Response Letter from FDA CDER to Boehringer Ingelheim Pharma GmbH & Co. KG, Hogan Lovells US LLP | Other | Answer | 2014-12-29T05:00:00Z | 2014 | 12 | 2014-12-29T05:00:00Z | 2014-12-29T18:32:45Z | 0 | 0 | 0900006481996e52 | ||
| FDA-2014-P-2301-0002 | FDA | FDA-2014-P-2301 | Acknowledgement Letter From FDA DDM to Probiomed S.A. de C.V., Mexico | Other | Acknowledgement Letter/Receipt | 2014-12-29T05:00:00Z | 2014 | 12 | 2014-12-29T05:00:00Z | 2014-12-29T20:01:03Z | 0 | 0 | 0900006481996c83 | ||
| FDA-1984-P-0032-0001 | FDA | Allow 5-Aminosalicylic Acid Suppostitiories be ANDA-CLOSED FDA-1984-P-0032 | Citizen Petition from Rowell Laboratories | Other | Citizen Petition | 2014-12-29T05:00:00Z | 2014 | 12 | 2014-12-29T05:00:00Z | 2022-05-26T17:37:09Z | 0 | 0 | 09000064805a820b | ||
| FDA-1984-P-0032-0003 | FDA | Allow 5-Aminosalicylic Acid Suppostitiories be ANDA-CLOSED FDA-1984-P-0032 | Letter from FDA to Rowell Laboratories re Confidentiality | Other | Letter(s) | 2014-12-29T05:00:00Z | 2014 | 12 | 2014-12-29T05:00:00Z | 2022-05-27T18:14:44Z | 0 | 0 | 09000064805a820d | ||
| FDA-2014-P-2301-0001 | FDA | FDA-2014-P-2301 | Citizen Petition From Probiomed S.A. de C.V. Mexico | Other | Citizen Petition | 2014-12-29T05:00:00Z | 2014 | 12 | 2014-12-29T05:00:00Z | 2024-11-12T05:31:36Z | 1 | 0 | 0900006481991a9e | ||
| FDA-1984-P-0032-0002 | FDA | Allow 5-Aminosalicylic Acid Suppostitiories be ANDA-CLOSED FDA-1984-P-0032 | Acknowledgement Letter to Rowell Laboratories | Other | Acknowledgement Letter/Receipt | 2014-12-29T05:00:00Z | 2014 | 12 | 2014-12-29T05:00:00Z | 2022-05-27T18:13:09Z | 0 | 0 | 09000064819975cd | ||
| FDA-2014-N-2214-0001 | FDA | FDA-2014-N-2214 | Next Generation Sequencing Diagnostic Tests Public Workshop Request for Comments | Notice | Request for Comments | 2014-12-29T05:00:00Z | 2014 | 12 | 2014-12-29T05:00:00Z | 2015-03-21T03:59:59Z | 2015-03-22T02:01:51Z | 2014-30308 | 0 | 0 | 0900006481995ff6 |
| FDA-1984-P-0032-0004 | FDA | Allow 5-Aminosalicylic Acid Suppostitiories be ANDA-CLOSED FDA-1984-P-0032 | Petition Denial Letter from FDA to Rowell Laboratories | Other | Denial | 2014-12-29T05:00:00Z | 2014 | 12 | 2014-12-29T05:00:00Z | 2022-05-27T18:15:22Z | 0 | 0 | 09000064805a820e | ||
| FDA-2014-N-2104-0001 | FDA | FDA-2014-N-2104 | Authorizations of Emergency Use of In Vitro Diagnostic Devices for Detection of Ebola Zaire Virus; Availability | Notice | Notice of Availability | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T05:00:00Z | 2014-12-24T19:05:36Z | 2014-30108 | 0 | 0 | 09000064819914d1 | |
| FDA-2014-D-1856-0005 | FDA | FDA-2014-D-1856 | Reference 2 Brown et al., Basic Science Review on Adipose Tissue for Clinicians re Human Cells Tissues, and Cellular and Tissue Based Products HCTPs From Adipose Tissue: Regulatory Consideration; Draft Guidance for Industry, FDA-2014-D-1856-0002 | Supporting & Related Material | Background Material | 2014-12-24T05:00:00Z | 2014 | 12 | 2015-01-02T15:19:45Z | 0 | 0 | 0900006481991c17 | |||
| FDA-2014-P-0919-0004 | FDA | FDA-2014-P-0919 | Interim Response from CDRH to Daniel Schumaier | Other | Response(s) | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T05:00:00Z | 2014-12-24T18:59:53Z | 0 | 0 | 0900006481991a9b | ||
| FDA-2013-S-0024-0472 | FDA | FDA-2013-S-0024 | Pharmavite - Maximum Strength D3 1000 IU - Vitamin D helps support heart health | Other | 30 Day Structured Function Claim | 2014-12-24T05:00:00Z | 2014 | 12 | 2017-06-12T20:36:49Z | 0 | 0 | 090000648199107a | |||
| FDA-2013-S-0024-0473 | FDA | FDA-2013-S-0024 | NOW Foods - Vitamin K2 - Supports bone health | Other | 30 Day Structured Function Claim | 2014-12-24T05:00:00Z | 2014 | 12 | 2017-06-12T20:48:29Z | 0 | 0 | 090000648199107b | |||
| FDA-2013-S-0024-0478 | FDA | FDA-2013-S-0024 | Highland Laboratories (Slim-Zymes) - Letter | Other | 30 Day Structured Function Claim | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T05:00:00Z | 2014-12-24T15:36:02Z | 0 | 0 | 0900006481990c88 | ||
| FDA-2010-N-0155-0207 | FDA | FDA-2010-N-0155 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Veterinary Feed Directive | Notice | 30 Day Proposed Information Collection | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T05:00:00Z | 2015-01-24T04:59:59Z | 2015-01-08T03:01:55Z | 2014-30157 | 0 | 0 | 090000648199147f |
| FDA-2014-N-2185-0002 | FDA | FDA-2014-N-2185 | Letter from FDA CFSAN Office of Nutritional Products, Labeling, and Dietary Supplements to Unilever North America, December 23, 2014 | Supporting & Related Material | Reference (internal unless indicated) | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T21:40:28Z | 0 | 0 | 090000648199247d | |||
| FDA-2014-D-1856-0002 | FDA | FDA-2014-D-1856 | Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) From Adipose Tissue: Regulatory Considerations; Draft Guidance for Industry | Other | Guidance | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T05:00:00Z | 2024-11-12T05:31:43Z | 1 | 0 | 0900006481991c12 | ||
| FDA-2013-S-0024-0470 | FDA | FDA-2013-S-0024 | Herb Pharm - Liquid Herbal Extract Soothing throat spray - Supports healthy function of the immune system | Other | 30 Day Structured Function Claim | 2014-12-24T05:00:00Z | 2014 | 12 | 2017-06-13T18:39:58Z | 0 | 0 | 0900006481991078 | |||
| FDA-2013-S-0024-0474 | FDA | FDA-2013-S-0024 | Highland Laboratories - Folic Acid and B12 original formula - Supports healthy RNA and DNA | Other | 30 Day Structured Function Claim | 2014-12-24T05:00:00Z | 2014 | 12 | 2017-06-12T20:53:17Z | 0 | 0 | 0900006481991081 | |||
| FDA-2009-F-0303-0031 | FDA | FDA-2009-F-0303 | Food Additives Permitted for Direct Addition to Food for Human Consumption: Advantame | Rule | Final Rule | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T18:21:53Z | 2014-30144 | 0 | 0 | 0900006481991334 | ||
| FDA-2014-D-1856-0004 | FDA | FDA-2014-D-1856 | Reference 1 Chapter 6 Adipose Tissue re Human Cells Tissues, and Cellular and Tissue Based Products HCTPs From Adipose Tissue: Regulatory Consideration; Draft Guidance for Industry, FDA-2014-D-1856-0002 | Supporting & Related Material | Background Material | 2014-12-24T05:00:00Z | 2014 | 12 | 2015-01-02T15:19:44Z | 0 | 0 | 0900006481991c15 | |||
| FDA-2014-D-1856-0001 | FDA | FDA-2014-D-1856 | Human Cells, Tissues, and Cellular and Tissue-Based Products From Adipose Tissue: Regulatory Considerations; Draft Guidance for Industry; Availability | Proposed Rule | Request for Comment | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T05:00:00Z | 2015-02-24T04:59:59Z | 2015-02-24T03:13:21Z | 2014-30142 | 0 | 0 | 09000064819914d3 |
| FDA-2013-S-0024-0471 | FDA | FDA-2013-S-0024 | Solstice Medicine Company - Tang Sheng Hair Nourishment Capsules Herbal Dietary Supplement - Supports the health of the hair and scalp | Other | 30 Day Structured Function Claim | 2014-12-24T05:00:00Z | 2014 | 12 | 2017-06-13T18:42:52Z | 0 | 0 | 0900006481991079 | |||
| FDA-2014-D-1461-0003 | FDA | FDA-2014-D-1461 | Rare Pediatric Disease Priority Review Vouchers; Extension of Comment Period | Notice | Extension of Comment Period | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T05:00:00Z | 2015-02-17T04:59:59Z | 2015-03-25T02:02:24Z | 2014-30154 | 0 | 0 | 09000064819914d2 |
| FDA-2013-S-0024-0469 | FDA | FDA-2013-S-0024 | Bayer HealthCare Consumer Care (Bayer) - One A Day® Men's Health Formula Multivitamin/Multimineral Supplement - Heart Health | Other | 30 Day Structured Function Claim | 2014-12-24T05:00:00Z | 2014 | 12 | 2017-06-13T18:32:17Z | 0 | 0 | 090000648199019e | |||
| FDA-2014-D-1856-0003 | FDA | FDA-2014-D-1856 | Reference List re Human Cells Tissues, and Cellular and Tissue Based Products HCTPs From Adipose Tissue: Regulatory Consideration; Draft Guidance for Industry, FDA-2014-D-1856-0002 | Supporting & Related Material | Background Material | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T20:22:25Z | 0 | 0 | 0900006481991c14 | |||
| FDA-2013-S-0024-0477 | FDA | FDA-2013-S-0024 | Highland Laboratories (Good Green Coffee Bean with Garcinia) - Letter | Other | 30 Day Structured Function Claim | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T05:00:00Z | 2014-12-24T15:33:28Z | 0 | 0 | 0900006481990c87 | ||
| FDA-2013-N-1529-0018 | FDA | FDA-2013-N-1529 | Medical Device Classification Procedures: Reclassification Petition: Content and Form; Technical Amendment | Rule | Final Rule | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T17:15:31Z | 2014-30141 | 0 | 0 | 090000648199128e | ||
| FDA-2014-N-0001-0103 | FDA | FDA-2014-N-0001 | General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting | Notice | Public Meetings | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T17:20:01Z | 2014-30149 | 0 | 0 | 0900006481991291 | ||
| FDA-2014-N-2185-0001 | FDA | FDA-2014-N-2185 | Letter from the Institute of Medicine of the National Academies to FDA CFSAN, May 5, 2004 | Supporting & Related Material | Reference (internal unless indicated) | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T21:40:21Z | 0 | 0 | 090000648199247c | |||
| FDA-2013-S-0024-0475 | FDA | FDA-2013-S-0024 | Highland Laboratories (Folic Acid and B12 Methylcobalamin) - Letter | Other | 30 Day Structured Function Claim | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T05:00:00Z | 2014-12-24T15:24:08Z | 0 | 0 | 0900006481990c85 | ||
| FDA-2013-S-0024-0476 | FDA | FDA-2013-S-0024 | Highland Laboratories (Good Minerals) - Letter | Other | 30 Day Structured Function Claim | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T05:00:00Z | 2014-12-24T15:27:12Z | 0 | 0 | 0900006481990c86 | ||
| FDA-2007-D-0369-0309 | FDA | FDA-2007-D-0369 | Bioequivalence Recommendations for Methylphenidate Hydrochloride Extended-Release Oral Suspension; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T05:00:00Z | 2015-02-24T04:59:59Z | 2015-02-24T03:14:02Z | 2014-30109 | 0 | 0 | 09000064819910d4 |
| FDA-2014-V-2274-0002 | FDA | FDA-2014-V-2274 | Acknowledgement Letter from FDA DDM to Kenjix | Other | Acknowledgement Letter/Receipt | 2014-12-23T05:00:00Z | 2014 | 12 | 2014-12-23T05:00:00Z | 2014-12-23T15:16:56Z | 0 | 0 | 090000648198f225 | ||
| FDA-2014-P-2276-0004 | FDA | FDA-2014-P-2276 | Exhibit 3 Citizen Petition From Alan Laboratories, Inc. | Supporting & Related Material | Background Material | 2014-12-23T05:00:00Z | 2014 | 12 | 2014-12-23T14:22:49Z | 0 | 0 | 090000648198e718 | |||
| FDA-2014-D-1696-0001 | FDA | FDA-2014-D-1696 | Minimal Manipulation of Human Cells Tissues and Cellular and Tissue Based Products Draft Guidance for Industry and Food and Drug Administration Staff Availability | Notice | Notice of Availability | 2014-12-23T05:00:00Z | 2014 | 12 | 2014-12-23T05:00:00Z | 2015-02-24T04:59:59Z | 2015-02-25T03:05:07Z | 2014-30011 | 0 | 0 | 090000648198eace |
| FDA-2014-P-2276-0002 | FDA | FDA-2014-P-2276 | Exhibit 1 Citizen Petition From Alan Laboratories, Inc. | Supporting & Related Material | Background Material | 2014-12-23T05:00:00Z | 2014 | 12 | 2014-12-23T14:22:26Z | 0 | 0 | 090000648198e714 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);